Interactions of the male contraceptive target EPPIN with semenogelin-1 and small organic ligands

Autor(es)

Gomes, Antoniel A. S. ; Santos, Natalia C. M. ; Rosa, Leonardo R. ; Borges, Rafael J. ; Fontes, Marcos R. M. ; Hamil, Katherine G. ; O'Rand, Michael G. ; Silva, Erick J. R.

• Tipo de documento: Artigo Científico
• Fonte: SCIENTIFIC REPORTS; v. 13, n. 1, p. 11-pg., 2023-09-01.

Resumo

Novel male contraceptives will promote gender equality in sharing contraceptive responsibility. The sperm-associated protein epididymal protease inhibitor (EPPIN) is a promising target for non-hormonal male contraception. EPPIN interacts with the semen coagulum protein semenogelin-1 (SEMG1) on the sperm surface, leading to transient inhibition of sperm motility after ejaculation. Small organic molecules targeting EPPIN's SEMG1-binding are under development as male contraceptives. Here, we combined computational approaches to uncover key aspects underlying EPPIN binding to SEMG1 and small organic ligands. We generated a human EPPIN model showing a typical arrangement of the WFDC (Whey-acid four disulfide core)-type and Kunitz-type domains, connected by a hinge region. Determining the EPPIN model's intrinsic motion by molecular dynamics simulations and normal mode analysis revealed a conformation, presenting a binding pocket that accommodates SEMG1Glu229-Gln247, EP055, and EP012. EPPIN's residues Phe63 and Lys68 (WFDC domain), Asp71 (hinge region), and Asn113, Asn114, and Asn115 (Kunitz domain) were identified as hot spots for SEMG1, EP055, and EP012 binding. Moreover, hydrophobic and hydrophilic residues in the WFDC and Kunitz domains allow plasma membrane anchoring, orienting the EPPIN binding pocket to the solvent. Targeting EPPIN's essential residues for its biomolecular interactions may improve the rational design of EPPIN ligands as spermiostatic compounds. (AU)

• Processo FAPESP: 21/06718-7 - Estudo translacional sobre a proteína espermática EPPIN como alvo farmacológico para contracepção masculina
• Beneficiário: Erick José Ramo da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores - Fase 2
• Processo FAPESP: 15/08227-0 - Estudo da EPPIN como macromolécula-alvo para contracepção masculina: desenvolvimento de modelo animal para avaliar a eficácia de fármacos contraceptivos masculinos
• Beneficiário: Erick José Ramo da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores
• Processo FAPESP: 21/04746-3 - Interactoma da proteína EPPIN no espermatozoide humano: caracterização funcional e aplicações em estratégias farmacológicas para contracepção masculina
• Beneficiário: Erick José Ramo da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Regular